Journal article icon

Journal article

A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening.

Abstract:

BACKGROUND: Prostate-specific antigen (PSA) has modest specificity for prostate cancer. A panel of four kallikrein markers (total PSA, free PSA, intact PSA, and kallikrein-related peptidase 2) is a highly accurate predictor of biopsy outcome. The clinical significance of biopsy-detectable cancers in men classified as low-risk by this panel remains unclear. METHODS: The Malmö Diet and Cancer study is a population-based cohort of 11,063 Swedish men aged 45 to 73 providing a blood sample at base...

Expand abstract

Actions


Access Document


Authors


Expand authors...
Journal:
Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Volume:
20
Issue:
2
Pages:
255-261
Publication date:
2011-02-05
DOI:
EISSN:
1538-7755
ISSN:
1055-9965
URN:
uuid:b32599c3-97b1-4fff-b9ef-57185470241f
Source identifiers:
365882
Local pid:
pubs:365882

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP